Chemical Structure : Tozorakimab
CAS No.: 2376858-66-9
货号: PC-24499Not For Human Use, Lab Use Only.
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33 (IL-33), blocks IL-33red and IL-33ox signalling, reduces inflammation and epithelial dysfunction.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33 (IL-33), blocks IL-33red and IL-33ox signalling, reduces inflammation and epithelial dysfunction.
Tozorakimab (MEDI-3506) inhibits reduced IL-33 (IL-33red) and oxidized IL-33 (IL-33ox) activities through distinct serum-stimulated 2 (ST2) and receptor for advanced glycation end products/epidermal growth factor receptor (RAGE/EGFR complex) signalling pathways.
Tozorakimab (MEDI-3506) has femtomolar affinity for IL-33red and a fast association rate (8.5 × 107 M-1 s-1), which is comparable to soluble ST2.
Tozorakimab (MEDI-3506) potently inhibits ST2-dependent inflammatory responses driven by IL-33 in primary human cells and in a murine model of lung epithelial injury.
Anti-[human IL-33], Human IgG1 lambda1, monoclonal antibody.
分子量 | 144660.00 | |
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
|
1. England E, et al. Sci Rep. 2023 Jun 17;13(1):9825.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright